NeuroMetrix Statistics
Total Valuation
NeuroMetrix has a market cap or net worth of $9.01 million. The enterprise value is -$5.66 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NeuroMetrix has 2.04 million shares outstanding. The number of shares has increased by 76.58% in one year.
| Current Share Class | 2.04M |
| Shares Outstanding | 2.04M |
| Shares Change (YoY) | +76.58% |
| Shares Change (QoQ) | +1.09% |
| Owned by Insiders (%) | 19.13% |
| Owned by Institutions (%) | 13.10% |
| Float | 1.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.05 |
| Forward PS | n/a |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.88, with a Debt / Equity ratio of 0.01.
| Current Ratio | 13.88 |
| Quick Ratio | 12.38 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.78% and return on invested capital (ROIC) is -27.90%.
| Return on Equity (ROE) | -42.78% |
| Return on Assets (ROA) | -26.32% |
| Return on Invested Capital (ROIC) | -27.90% |
| Return on Capital Employed (ROCE) | -50.70% |
| Revenue Per Employee | $144,914 |
| Profits Per Employee | -$295,203 |
| Employee Count | 26 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.02% in the last 52 weeks. The beta is 2.16, so NeuroMetrix's price volatility has been higher than the market average.
| Beta (5Y) | 2.16 |
| 52-Week Price Change | +4.02% |
| 50-Day Moving Average | 4.35 |
| 200-Day Moving Average | 3.98 |
| Relative Strength Index (RSI) | 50.97 |
| Average Volume (20 Days) | 4,124 |
Short Selling Information
The latest short interest is 1,548, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 1,548 |
| Short Previous Month | 2,456 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.10% |
| Short Ratio (days to cover) | 0.21 |
Income Statement
In the last 12 months, NeuroMetrix had revenue of $3.77 million and -$7.68 million in losses. Loss per share was -$4.39.
| Revenue | 3.77M |
| Gross Profit | 2.20M |
| Operating Income | -8.10M |
| Pretax Income | -7.94M |
| Net Income | -7.68M |
| EBITDA | -8.00M |
| EBIT | -8.10M |
| Loss Per Share | -$4.39 |
Full Income StatementBalance Sheet
The company has $14.83 million in cash and $142,621 in debt, giving a net cash position of $14.69 million or $7.19 per share.
| Cash & Cash Equivalents | 14.83M |
| Total Debt | 142,621 |
| Net Cash | 14.69M |
| Net Cash Per Share | $7.19 |
| Equity (Book Value) | 15.98M |
| Book Value Per Share | 7.86 |
| Working Capital | 15.59M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.69 million and capital expenditures -$45,366, giving a free cash flow of -$6.73 million.
| Operating Cash Flow | -6.69M |
| Capital Expenditures | -45,366 |
| Free Cash Flow | -6.73M |
| FCF Per Share | -$3.30 |
Full Cash Flow StatementMargins
Gross margin is 58.40%, with operating and profit margins of -215.02% and -203.71%.
| Gross Margin | 58.40% |
| Operating Margin | -215.02% |
| Pretax Margin | -203.71% |
| Profit Margin | -203.71% |
| EBITDA Margin | -212.39% |
| EBIT Margin | -215.02% |
| FCF Margin | n/a |